|
91 |
DNA-methylome-assisted classification of patients with poor prognostic subventricular zone associated IDH-wildtype glioblastoma
Enthalten in Acta neuropathologica Bd. 144, 4.6.2022, Nr. 1, date:7.2022: 129-142
|
|
|
|
92 |
Does age matter? - A MRI study on peritumoral edema in newly diagnosed primary glioblastoma
Enthalten in BMC cancer Bd. 11, 12.4.2011, Nr. 1, date:12.2011: 1-8
|
|
|
|
93 |
Emergency intubation during thrombectomy for acute ischemic stroke in patients under primary procedural sedation
Enthalten in Neurological research and practice Bd. 3, 17.5.2021, Nr. 1, date:12.2021: 1-8
|
|
|
|
94 |
Epigenetic landscape reorganisation and reactivation of embryonic development genes are associated with malignancy in IDH-mutant astrocytoma
Enthalten in Acta neuropathologica Bd. 148, 9.10.2024, Nr. 1, date:12.2024: 1-18
|
|
|
|
95 |
Gain of 12p encompassing CCND2 is associated with gemistocytic histology in IDH mutant astrocytomas
Enthalten in Acta neuropathologica Bd. 133, 20.12.2016, Nr. 2, date:2.2017: 325-327
|
|
|
|
96 |
Genetical and epigenetical profiling identifies two subgroups of pineal parenchymal tumors of intermediate differentiation (PPTID) with distinct molecular, histological and clinical characteristics
Enthalten in Acta neuropathologica Bd. 146, 30.9.2023, Nr. 6, date:12.2023: 853-856
|
|
|
|
97 |
Glioblastomas with primitive neuronal component harbor a distinct methylation and copy-number profile with inactivation of TP53, PTEN, and RB1
Enthalten in Acta neuropathologica Bd. 142, 19.4.2021, Nr. 1, date:7.2021: 179-189
|
|
|
|
98 |
Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusions
Enthalten in Acta neuropathologica Bd. 145, 18.3.2023, Nr. 5, date:5.2023: 667-680
|
|
|
|
99 |
Glutamatergic synaptic input to glioma cells drives brain tumour progression
Enthalten in Nature Bd. 573, 18.9.2019, Nr. 7775, date:9.2019: 532-538
|
|
|
|
100 |
GOPC:ROS1 and other ROS1 fusions represent a rare but recurrent drug target in a variety of glioma types
Enthalten in Acta neuropathologica Bd. 142, 18.9.2021, Nr. 6, date:12.2021: 1065-1069
|
|
Administration
